aldosterone and Kidney Diseases studies

Research Excerpts

Excerpt	Relevance	Reference
"Pentoxifylline added to losartan therapy for 1 year decreased proteinuria in patients with CKD stages 3 to 5."	9.13	Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial. ( Chen, YM; Chiang, WC; Lin, SL; Tsai, TJ; Wu, KD, 2008)
"Six adult patients (4 females and 2 males, age range 26-57 years) with Gitelman's syndrome (GS) were treated with spironolactone 200-300 mg/day (n = 5) and/or amiloride 10-30 mg/day (n = 3) for 1-18 months."	7.69	Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. ( Colussi, G; De Ferrari, ME; Macaluso, M; Minetti, L; Rombolà, G, 1994)
"Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics."	7.67	Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984)
" Furthermore, acute and chronic administrations of clonidine were used to determine a participation of the sympathetic nervous system in the maintenance of hypertension in these patients."	7.67	Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine. ( Campese, VM; Levitan, D; Massry, SG; Romoff, M, 1984)
"Five patients with hepatorenal syndrome were treated with the orally active angiotensin-converting enzyme inhibitor captopril (25 or 50 mg 6 hourly) for up to 48 hours."	7.67	Captopril in the hepatorenal syndrome. ( Cobden, I; Record, CO; Shore, A; Wilkinson, R, 1985)
"Nine hypertensive patients with mild to moderate renal dysfunction were entered into a protocol to assess the blood pressure, humoral and renal effects of the angiotensin converting enzyme inhibitor, Benazepril (CGS14824A, 2 to 20 mg twice daily) in patients with hypertension and moderate renal insufficiency (mean creatinine clearance 56 ml/min/1."	7.67	Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction. ( Bauer, JH; Lau, A; Reams, GP, 1989)
" have applied the diazoxide test for the screening of primary hiperaldosteronism to 22 nephropatic patients suffering from hypertension and with different degrees of renal function."	7.65	[Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function]. ( Albertini, A; Cecchettin, M; Ghielmi, S; Maiorca, R; Orlandini, A; Signorini, C, 1975)
"Captopril was administered orally in 2 daily doses of 25 to 200 mg."	6.65	Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. ( Brunner, HR; Gavras, H; Guignard, JP; Turini, GA; Waeber, B; Wauters, JP, 1981)
" The observation of reduced nitric oxide bioavailability in hyperaldosteronism implied the generation of oxidative stress by aldosterone."	6.48	Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases. ( Queisser, N; Schupp, N, 2012)
"Aldosterone has been reported to induce IL-18, resulting in cardiac fibrosis with induced IL-18-mediated osteopontin (OPN)."	5.43	Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice. ( Enomoto, D; Higaki, J; Kukida, M; Miyoshi, K; Nagao, T; Okamura, H; Okura, T; Pei, Z; Tanino, A, 2016)
"Aldosterone-salt treatment induces not only hypertension but also extensive inflammation that contributes to fibrosis in the rat kidney."	5.40	Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats. ( Doi, S; Doi, T; Kohno, N; Masaki, T; Nakashima, A; Ueno, T; Yokoyama, Y, 2014)
" This dosage was well tolerated."	5.28	Nilvadipine in hypertension with renal dysfunction. ( Albert, FW; Berger, HH, 1992)
""Outpatient hyperkalemia" is a new clinical syndrome in which high serum potassium levels (SK) are found in the outpatient condition returning toward normal without any specific treatment after admission to the hospital."	5.26	"Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production. ( Boer, P; Dorhout Mees, EJ; Rado, JP; Simatupang, T, 1979)
"Pentoxifylline added to losartan therapy for 1 year decreased proteinuria in patients with CKD stages 3 to 5."	5.13	Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial. ( Chen, YM; Chiang, WC; Lin, SL; Tsai, TJ; Wu, KD, 2008)
"Cyclosporin A (CyA) and azathioprine (Aza) were compared with respect to renal side effects in an open controlled, randomized study of patients with rheumatoid arthritis."	5.06	Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. ( Amundsen, E; Berg, KJ; Bjerkhoel, F; Djøseland, O; Førre, O; Rugstad, HE; Westre, B, 1986)
"In a 16-week study, eplerenone was more effective than placebo or losartan in lowering systolic blood pressure (BP) and diastolic BP in black patients with mild to moderate hypertension."	4.81	Clinical implications of aldosterone blockade. ( Weber, MA, 2002)
"A unique model of hypertension developed in our laboratory shows that neonatal degeneration of capsaicin-sensitive sensory nerves renders a rat responsive to salt load with a significant rise in blood pressure."	3.72	Increased salt sensitivity induced by impairment of sensory nerves: is nephropathy the cause? ( Wang, DH; Zhao, Y, 2003)
" Although the patient had some clinical similarities to Bartter's syndrome, fractional sodium chloride (NaCl) reabsorption during hypotonic saline diuresis was normal and no clinical amelioration was observed while on indomethacin therapy."	3.69	Salt-losing nephropathy associated with inappropriate secretion of atrial natriuretic peptide--a new clinical syndrome. ( Rodríguez-Soriano, J; Vallo, A, 1997)
"Six adult patients (4 females and 2 males, age range 26-57 years) with Gitelman's syndrome (GS) were treated with spironolactone 200-300 mg/day (n = 5) and/or amiloride 10-30 mg/day (n = 3) for 1-18 months."	3.69	Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. ( Colussi, G; De Ferrari, ME; Macaluso, M; Minetti, L; Rombolà, G, 1994)
" Furthermore, acute and chronic administrations of clonidine were used to determine a participation of the sympathetic nervous system in the maintenance of hypertension in these patients."	3.67	Plasma catecholamines and autonomic nervous system function in patients with early renal insufficiency and hypertension: effect of clonidine. ( Campese, VM; Levitan, D; Massry, SG; Romoff, M, 1984)
"Nine hypertensive patients with mild to moderate renal dysfunction were entered into a protocol to assess the blood pressure, humoral and renal effects of the angiotensin converting enzyme inhibitor, Benazepril (CGS14824A, 2 to 20 mg twice daily) in patients with hypertension and moderate renal insufficiency (mean creatinine clearance 56 ml/min/1."	3.67	Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction. ( Bauer, JH; Lau, A; Reams, GP, 1989)
"Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics."	3.67	Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984)
"Five patients with hepatorenal syndrome were treated with the orally active angiotensin-converting enzyme inhibitor captopril (25 or 50 mg 6 hourly) for up to 48 hours."	3.67	Captopril in the hepatorenal syndrome. ( Cobden, I; Record, CO; Shore, A; Wilkinson, R, 1985)
"The effects of monotherapy with nicardipine, 20 mg three times a day, have been investigated in a 1-year study of 26 elderly (greater than 60 years) patients with hypertension with various types of renal dysfunction and seven without renal dysfunction."	3.67	Effects of nicardipine on blood pressure and renal function in elderly hypertensive patients with renal dysfunction. ( Saruta, T, 1989)
" have applied the diazoxide test for the screening of primary hiperaldosteronism to 22 nephropatic patients suffering from hypertension and with different degrees of renal function."	3.65	[Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function]. ( Albertini, A; Cecchettin, M; Ghielmi, S; Maiorca, R; Orlandini, A; Signorini, C, 1975)
" Group H showed significantly smaller furosemide dosage in the initial 3 days (H vs."	2.71	Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm. ( Akedo, H; Hayashi, Y; Hiraishi, T; Kobayashi, Y; Matsuda, H; Ohtani, M; Sawa, Y, 2003)
" The effects of intravenous metoclopramide on baseline values and dopamine dose-response curves for renal haemodynamics and natriuresis were investigated in healthy volunteers and patients with renal disease."	2.66	Effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease. ( Donker, AJ; Meijer, S; Reitsma, WD; Smit, AJ; Wesseling, H, 1988)
"Primary aldosteronism is common and contributes to adverse cardiovascular, kidney, and metabolic outcomes."	2.66	MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism. ( Hundemer, GL; Vaidya, A, 2020)
"Captopril was administered orally in 2 daily doses of 25 to 200 mg."	2.65	Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. ( Brunner, HR; Gavras, H; Guignard, JP; Turini, GA; Waeber, B; Wauters, JP, 1981)
" The observation of reduced nitric oxide bioavailability in hyperaldosteronism implied the generation of oxidative stress by aldosterone."	2.48	Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases. ( Queisser, N; Schupp, N, 2012)
"Especially in patients with primary hyperaldosteronism (PHA) a significant higher risk of developing cardiovascular comorbidities and comortalities was reported."	2.48	Aldosterone and the kidney. ( Fourkiotis, VG; Hanslik, G; Hanusch, F; Lepenies, J; Quinkler, M, 2012)
"Aldosterone is an adrenal hormone that regulates sodium, fluid, and potassium balance."	2.45	Aldosterone and cardiovascular disease. ( Calhoun, DA; Gaddam, KK; Husain, S; Pimenta, E, 2009)
"Aldosterone plays a significant role in the pathogenesis of arterial hypertension and renal disease."	2.44	Aldosterone and progression of renal disease. ( Wenzel, U, 2008)
"Anti-aldosterone treatment has proven effective in patients with heart failure."	2.44	Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade. ( Cusi, D; Del Vecchio, L; Procaccio, M; Viganò, S, 2007)
"Aldosterone has recently been recognized as an important factor in the development and progression of cardiorenal disease."	2.43	Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial? ( Coca, SG; Perazella, MA, 2005)
"Aldosterone has been overlooked as a mediator of RAAS escape and a key factor in target-organ injury despite the use of available RAAS blockers."	2.42	RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease. ( Lakkis, J; Lu, WX; Weir, MR, 2003)
"Hypertension is a major risk factor for progressive renal disease."	2.41	Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift. ( Epstein, M, 2001)
"The various types of renal tubular acidosis have manifold facets but the basic understanding of their pathophysiology begins with the concept of the "anion gap," a point of reference that can be used in the differential diagnosis and treatment."	2.36	Acid-base disorders and the kidney. ( Chan, JC, 1983)
"Drug treatment of renal hypertension is not essentially different from that of essential hypertension."	2.35	[Renal hypertension]. ( Reubi, F; Weidmann, P, 1976)
"Renal fibrosis is an inevitable process in the progression of chronic kidney disease (CKD)."	1.91	Esaxerenone Inhibits Renal Angiogenesis and Endothelial-Mesenchymal Transition via the VEGFA and TGF-β1 Pathways in Aldosterone-Infused Mice. ( Chang, J; Chang, Y; Fan, L; Gao, X; Liu, Z; Shimosawa, T; Xu, Q; Yang, F; Zhang, C, 2023)
"Intradialytic hypotension is a major complication during hemodialysis session, associated with increased risk of cardiovascular events and mortality."	1.51	Intradialytic hypotension: beyond hemodynamics. ( Assaad, S; Chacra, D; Chelala, D; Fares, N; Hajal, J; Joubran, N; Saliba, Y; Sleilaty, G, 2019)
"Aldosterone has been reported to induce IL-18, resulting in cardiac fibrosis with induced IL-18-mediated osteopontin (OPN)."	1.43	Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice. ( Enomoto, D; Higaki, J; Kukida, M; Miyoshi, K; Nagao, T; Okamura, H; Okura, T; Pei, Z; Tanino, A, 2016)
"We describe the clinical course of renal tubular acidosis (RTA) type 4 in pregnancy, which has not been previously published."	1.43	Renal tubular acidosis type 4 in pregnancy. ( Baynes, K; Jakes, AD; Nelson-Piercy, C, 2016)
"Aldosterone predicts new HTN, central obesity, T2DM, and use of lipid-lowering drugs in the general community and remains associated with HTN, obesity, and CKD over 4 years."	1.42	Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up. ( Bailey, KR; Buglioni, A; Burnett, JC; Cannone, V; Heublein, DM; Rodeheffer, RJ; Sangaralingham, SJ; Sarzani, R; Scott, CG, 2015)
"Celecoxib (40 mg/kg) was co-administered once daily to one vehicle and one misoprostol group from days 3 to 9."	1.40	Exacerbation of celecoxib-induced renal injury by concomitant administration of misoprostol in rats. ( Bullins, KW; Campbell, GE; Conder, CM; Cooper, DL; Denham, JW; Hanley, AV; Harirforoosh, S; Lynch, SP; Murrell, DE; Palau, VE; Panus, PC; Singh, K, 2014)
"Aldosterone-salt treatment induces not only hypertension but also extensive inflammation that contributes to fibrosis in the rat kidney."	1.40	Mizoribine ameliorates renal injury and hypertension along with the attenuation of renal caspase-1 expression in aldosterone-salt-treated rats. ( Doi, S; Doi, T; Kohno, N; Masaki, T; Nakashima, A; Ueno, T; Yokoyama, Y, 2014)
"CVD mortality and sudden cardiac death events at 7."	1.37	Association of plasma aldosterone with cardiovascular mortality in patients with low estimated GFR: the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. ( Boehm, BO; Drechsler, C; Grammer, T; März, W; Pilz, S; Ritz, E; Tomaschitz, A, 2011)
"Hypertension is a leading contributor to cardiovascular mortality worldwide."	1.37	Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. ( Ando, K; Ayuzawa, N; Fujita, T; Ishikawa, A; Ishizawa, K; Kawarazaki, H; Kawarazaki, W; Miyoshi, J; Mu, S; Muraoka, K; Nagase, M; Shibata, S; Shimosawa, T; Takai, Y; Takeuchi, M; Yoshida, S, 2011)
" RI was compared to the ARB, candesartan (3 mg/kg/day PO), and to the ACEI, enalapril (60 mg/kg/day PO) in a 4-week dosing paradigm."	1.35	A nonpeptide, piperidine renin inhibitor provides renal and cardiac protection in double-transgenic mice expressing human renin and angiotensinogen genes. ( Carlson, T; Kowala, MC; Leadley, R; Major, TC; Okerberg, C; Olszewski, B; Ostroski, R; Rosebury, W; Schroeder, R, 2008)
"Both fibrinogen and PAI-1 were independent predictors of the presence of organ damage and their inclusion in a multivariate model eliminated PRA and aldosterone as independent predictors."	1.35	Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. ( Casanova-Borca, A; Catena, C; Chiuch, A; Colussi, G; Di Fabio, A; Nadalini, E; Novello, M; Sechi, LA; Uzzau, A, 2008)
"To evaluate the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function."	1.35	Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. ( Cerasola, G; Cottone, S; Cusimano, P; Mulè, G; Nardi, E; Palermo, A, 2009)
"In aldosterone-infused rats, treatment with a nonspecific vasodilator, hydralazine (5 mg/kg per day in drinking water) resulted in a reduction in SBP similar to azelnidipine; however, it did not affect any renal parameters."	1.35	Inhibitory effects of a dihydropyridine calcium channel blocker on renal injury in aldosterone-infused rats. ( Du, J; Fan, YY; Fu, H; Fujisawa, Y; Hitomi, H; Hosomi, N; Kimura, S; Kiyomoto, H; Kohno, M; Lu, XM; Nagai, Y; Nakano, D; Nishiyama, A; Ohmori, K, 2009)
"Spironolactone treatment prevents renal damage induced by ischemia-reperfusion (I/R), suggesting that renoprotection conferred by spironolactone is mediated by mineralocorticoid receptor (MR) blockade."	1.35	Adrenalectomy prevents renal ischemia-reperfusion injury. ( Bobadilla, NA; Cruz, C; Gamba, G; Ramírez, V; Trujillo, J; Uribe, N; Valdes, R, 2009)
"At baseline, patients with primary aldosteronism had higher creatinine clearance and albuminuria than 323 patients with essential hypertension and 113 normotensive individuals."	1.34	Relationships of plasma renin levels with renal function in patients with primary aldosteronism. ( Baroselli, S; Catena, C; Chiuch, A; Colussi, G; Lapenna, R; Nadalini, E; Sechi, LA, 2007)
"Hypokalemia is a prominent feature of Gitelman syndrome and a common side effect of thiazide use in the treatment of hypertension."	1.33	Hypokalemia in a mouse model of Gitelman's syndrome. ( Hoorn, EJ; Knepper, MA; Morris, RG, 2006)
"Aldosterone plays a key role in the pathogenesis of Ang II-induced organ damage."	1.33	Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage. ( Al-Saadi, N; Dechend, R; Fiebeler, A; Hilfenhaus, G; Jeng, AY; Luft, FC; Maser-Gluth, C; Meiners, S; Muller, DN; Nussberger, J; Rong, S; Shagdarsuren, E; Webb, RL; Wellner, M, 2005)
"Primary hyperaldosteronism was diagnosed on the basis of plasma concentrations of aldosterone (PAC) and plasma renin activity (PRA), and the calculation of the PAC:PRA ratio."	1.33	Primary hyperaldosteronism, a mediator of progressive renal disease in cats. ( Boer, WH; Djajadiningrat-Laanen, SC; Javadi, S; Kooistra, HS; Rijnberk, A; van den Ingh, TS; van Dongen, AM; van Sluijs, FJ; Voorhout, G, 2005)
"Aldosterone treatment of cells resulted in significant up-regulation of several genes within 1 hour, with sgk, p21/waf1, gadd45, and gadd153 being the most significant ones."	1.32	Early aldosterone up-regulated genes: new pathways for renal disease? ( Christ, M; Falkenstein, E; Feuring, M; Hafner, M; Kellner, M; Lösel, R; Peiter, A; Wehling, M, 2003)
"Spironolactone treatment decreased PAI-1 immunoreactivity and reduced in a dose-dependent fashion cardiac and renal damage."	1.32	Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury. ( Adler, GK; Jonasson, L; Martinez-Vasquez, D; Mukasa, K; Oestreicher, EM; Roubsanthisuk, W; Stone, JR, 2003)
" This dosage was well tolerated."	1.28	Nilvadipine in hypertension with renal dysfunction. ( Albert, FW; Berger, HH, 1992)
""Outpatient hyperkalemia" is a new clinical syndrome in which high serum potassium levels (SK) are found in the outpatient condition returning toward normal without any specific treatment after admission to the hospital."	1.26	"Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone production. ( Boer, P; Dorhout Mees, EJ; Rado, JP; Simatupang, T, 1979)

Timeframe	Studies, this research(%)	All Research%
pre-1990	174 (46.65)	18.7374
1990's	19 (5.09)	18.2507
2000's	94 (25.20)	29.6817
2010's	70 (18.77)	24.3611
2020's	16 (4.29)	2.80

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients[NCT04515095]		30 participants (Actual)	Interventional	2020-08-16	Completed
Prospective Cross-sectional Study on Prevalence of Primary Aldosteronism in Resistant Hypertension and Association With Cardiometabolic Complications[NCT04213963]		100 participants (Anticipated)	Observational	2011-09-01	Recruiting
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension[NCT05593055]	Phase 4	75 participants (Anticipated)	Interventional	2023-08-25	Recruiting
Genetic Predisposition of Chronic Nephrotoxicity From Calcineurin Inhibitors in Liver Transplant Recipients, Potential Correlation With Urinary Biomarkers[NCT00857844]		207 participants (Actual)	Observational	2007-07-31	Completed
Usefulness of Spironolactone for the Prevention of Acute Kidney Injury in Critically Ill Patients With Invasive Mechanical Ventilation[NCT03206658]	Phase 3	90 participants (Anticipated)	Interventional	2017-08-01	Not yet recruiting
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?[NCT00291720]	Phase 2	120 participants (Actual)	Interventional	2005-04-30	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders - New perspectives for combination therapy. Pharmacological research, 2021, Volume: 172 Topics: Aldosterone; Animals; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Kidney Diseases; M	2021
Approaches towards tissue-selective pharmacology of the mineralocorticoid receptor. British journal of pharmacology, 2022, Volume: 179, Issue:13 Topics: Aldosterone; Humans; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocor	2022
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2022, Volume: 71, Issue:1 Topics: Acute Kidney Injury; Aldosterone; Angiotensins; Antibodies, Monoclonal, Humanized; Autopsy; Biopsy;	2022
Vascular and inflammatory mineralocorticoid receptors in kidney disease. Acta physiologica (Oxford, England), 2020, Volume: 228, Issue:2 Topics: Aldosterone; Animals; Endothelium, Vascular; Humans; Inflammation; Kidney Diseases; Muscle, Smooth,	2020
Genetic renal disease classification by hormonal axes. Pediatric nephrology (Berlin, Germany), 2020, Volume: 35, Issue:12 Topics: Aldosterone; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Kidney Dis	2020
Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease. Chemico-biological interactions, 2020, Feb-01, Volume: 317 Topics: Adrenal Cortex Hormones; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzym	2020
MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism. European journal of endocrinology, 2020, Volume: 183, Issue:6 Topics: Adrenalectomy; Aldosterone; Endocrine System Diseases; Heart Diseases; Humans; Hyperaldosteronism; K	2020
The renin-angiotensin-aldosterone system and its suppression. Journal of veterinary internal medicine, 2019, Volume: 33, Issue:2 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit	2019
A potential role of the renin-angiotensin-aldosterone system in epithelial-to-mesenchymal transition-induced renal abnormalities: Mechanisms and therapeutic implications. Pharmacological research, 2019, Volume: 146 Topics: Aldosterone; Animals; Epithelial Cells; Epithelial-Mesenchymal Transition; Humans; Kidney Diseases;	2019
ENaC modulators and renal disease. Current molecular pharmacology, 2013, Volume: 6, Issue:1 Topics: Aldosterone; Diuretics; Epithelial Sodium Channel Agonists; Epithelial Sodium Channel Blockers; Epit	2013
Renal microcirculation and calcium channel subtypes. Current hypertension reviews, 2013, Volume: 9, Issue:3 Topics: Aldosterone; Animals; Arterioles; Calcium Channel Blockers; Calcium Channels; Glomerular Filtration	2013
Claudins and the kidney. Journal of the American Society of Nephrology : JASN, 2015, Volume: 26, Issue:1 Topics: Aldosterone; Cations; Claudins; Epithelial Cells; Epithelium; Humans; Kidney; Kidney Diseases; Kidne	2015
Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:2 Topics: 11-beta-Hydroxysteroid Dehydrogenases; Aldosterone; Animals; Blood Pressure; Clinical Trials as Topi	2015
Genome-wide meta-analyses of plasma renin activity and concentration reveal association with the kininogen 1 and prekallikrein genes. Circulation. Cardiovascular genetics, 2015, Volume: 8, Issue:1 Topics: Aldosterone; Cardiovascular Diseases; Genome-Wide Association Study; Humans; Kidney Diseases; Kinino	2015
Therapeutic targeting of aldosterone: a novel approach to the treatment of glomerular disease. Clinical science (London, England : 1979), 2015, Volume: 128, Issue:9 Topics: Aldosterone; Animals; Drug Design; Fibrosis; Humans; Kidney Diseases; Kidney Glomerulus; Mineralocor	2015
MicroRNAs and the regulation of aldosterone signaling in the kidney. American journal of physiology. Cell physiology, 2015, Apr-01, Volume: 308, Issue:7 Topics: Aldosterone; Animals; Humans; Kidney; Kidney Diseases; MicroRNAs; Signal Transduction	2015
Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology. Pharmacological reviews, 2016, Volume: 68, Issue:1 Topics: Aging; Aldosterone; Cardiovascular Diseases; Eye Diseases; Fibrosis; Humans; Inflammation; Ion Chann	2016
The potential of targeting CYP11B. Expert opinion on therapeutic targets, 2016, Volume: 20, Issue:8 Topics: Aldosterone; Animals; Cardiomegaly; Cytochrome P-450 CYP11B2; Drug Design; Humans; Hypertension; Imi	2016
Novel aspects of the renin-angiotensin-aldosterone-system. Frontiers in bioscience : a journal and virtual library, 2008, May-01, Volume: 13 Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Humans; Kidney Diseases; Kidney Failure, Chro	2008
Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. Journal of pharmacological sciences, 2008, Volume: 108, Issue:4 Topics: Aldosterone; Animals; Eplerenone; Humans; Kidney; Kidney Diseases; Mitogen-Activated Protein Kinases	2008
Aldosterone and cardiovascular disease. Current problems in cardiology, 2009, Volume: 34, Issue:2 Topics: Adrenalectomy; Aldosterone; Animals; Antihypertensive Agents; Cardiovascular Agents; Cardiovascular	2009
Extracellular volume and aldosterone interaction in chronic kidney disease. Blood purification, 2009, Volume: 27, Issue:1 Topics: Aldosterone; Cardiovascular Diseases; Chronic Disease; Extracellular Fluid; Fibrosis; Humans; Inflam	2009
Aldosterone and progression of kidney disease. Therapeutic advances in cardiovascular disease, 2009, Volume: 3, Issue:2 Topics: Aldosterone; Animals; Chronic Disease; Clinical Trials as Topic; Disease Models, Animal; Disease Pro	2009
Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review. American journal of nephrology, 2009, Volume: 30, Issue:2 Topics: Aldosterone; Animals; Diabetes Complications; Humans; Hypertension; Insulin Resistance; Kidney; Kidn	2009
Investigating hypertension in a young person. BMJ (Clinical research ed.), 2009, Apr-06, Volume: 338 Topics: Adult; Aldosterone; Humans; Hypertension; Kidney Diseases; Male; Referral and Consultation; Renin; U	2009
[Aldosterone block in proteinuria]. Nederlands tijdschrift voor geneeskunde, 2009, Apr-11, Volume: 153, Issue:15 Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Disease Progression; Humans; Kidney Diseases;	2009
Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Annals of internal medicine, 2009, Jun-02, Volume: 150, Issue:11 Topics: Aldosterone; Cardiovascular Diseases; Endothelium, Vascular; Humans; Hypertension; Insulin Resistanc	2009
[Novel evidence for sodium sensitivity and renal impairment]. Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:4 Topics: Aldosterone; Blood Pressure; Circadian Rhythm; Glomerular Filtration Rate; Kidney; Kidney Diseases;	2009
Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination. American journal of hypertension, 2009, Volume: 22, Issue:10 Topics: Aldosterone; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibito	2009
Mineralocorticoid receptor blockers and chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:10 Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Chronic Disease; Drug Therapy, Combination; Hu	2009
Aldosterone and cardiovascular risk. Current hypertension reports, 2009, Volume: 11, Issue:6 Topics: Aldosterone; Antihypertensive Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins;	2009
[Chronic kidney disease and the aldosterone/mineralocorticoid receptor system]. Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:2 Topics: Aldosterone; Animals; Chronic Disease; Eplerenone; Humans; Kidney Diseases; Metabolic Syndrome; Mine	2010
Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clinical and experimental nephrology, 2010, Volume: 14, Issue:4 Topics: Aldosterone; Animals; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; Humans; Hypertensi	2010
Aldosterone blockade in chronic kidney disease: can it improve outcome? Current opinion in nephrology and hypertension, 2010, Volume: 19, Issue:5 Topics: Aldosterone; Blood Pressure; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Hum	2010
[Possibilities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system]. Terapevticheskii arkhiv, 2010, Volume: 82, Issue:6 Topics: Aldosterone; Angiotensins; Cardiovascular Diseases; Clinical Laboratory Techniques; Humans; Kidney D	2010
[Aldosterone and kidney diseases: an emergent paradigm with important clinical implications]. Nephrologie & therapeutique, 2011, Volume: 7, Issue:3 Topics: Aldosterone; Animals; Humans; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Receptors, Mi	2011
Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney. Journal of pharmacological sciences, 2011, Volume: 115, Issue:1 Topics: Aldosterone; Animals; Blood Pressure; Electrolytes; Eplerenone; Homeostasis; Humans; Kidney; Kidney	2011
The regulation of cell growth and survival by aldosterone. Frontiers in bioscience (Landmark edition), 2011, 01-01, Volume: 16, Issue:2 Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Aldosterone; Animals; Blood Vessels; Brain; Cardiovascu	2011
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease. Kidney international, 2011, Volume: 79, Issue:10 Topics: Aldosterone; Animals; Chronic Disease; Cyclosporine; Diabetic Nephropathies; Humans; Kidney Diseases	2011
Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatric nephrology (Berlin, Germany), 2011, Volume: 26, Issue:10 Topics: Adult; Aldosterone; Bartter Syndrome; Female; Gitelman Syndrome; Humans; Hyperaldosteronism; Kidney	2011
[Bone and calcium update; research of calcium metabolism on cardiovascular system update. Calcium channel blocker update]. Clinical calcium, 2011, Volume: 21, Issue:12 Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Calcium Channels; C	2011
Aldosterone and the kidney. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2012, Volume: 44, Issue:3 Topics: Aldosterone; Animals; Humans; Hyperaldosteronism; Kidney; Kidney Diseases; Receptors, Mineralocortic	2012
[Kidney diseases and mineralocorticoid receptor]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2009, Nov-10, Volume: 98, Issue:11 Topics: Aldosterone; Animals; Humans; Kidney Diseases; Metabolic Syndrome; Mineralocorticoid Receptor Antago	2009
Aldosterone, oxidative stress, and NF-κB activation in hypertension-related cardiovascular and renal diseases. Free radical biology & medicine, 2012, Jul-15, Volume: 53, Issue:2 Topics: Aldosterone; Animals; Cardiovascular Diseases; Disease Models, Animal; Heart Failure; Humans; Hypera	2012
Salt, aldosterone and hypertension. Journal of human hypertension, 2013, Volume: 27, Issue:1 Topics: Aldosterone; Animals; Appetite; Cardiovascular Diseases; Humans; Hyperaldosteronism; Hypertension; K	2013
[Mineralocorticoid receptor: an update]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70, Issue:9 Topics: Aldosterone; Animals; Heart Diseases; Humans; Kidney Diseases; Mineralocorticoid Receptor Antagonist	2012
Clinical implications of aldosterone blockade. American heart journal, 2002, Volume: 144, Issue:5 Suppl Topics: Aldosterone; Antihypertensive Agents; Black People; Blood Pressure; Cardiovascular Diseases; Clinica	2002
Aldosterone in renal disease. Current opinion in nephrology and hypertension, 2003, Volume: 12, Issue:2 Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Clinical Trials as	2003
Negative regulators of sodium transport in the kidney: key factors in understanding salt-sensitive hypertension? The Journal of clinical investigation, 2003, Volume: 111, Issue:7 Topics: Aldosterone; Animals; Biological Transport; Blood Pressure; Humans; Hypertension; Hypotension; Kidne	2003
Eplerenone, a new selective aldosterone blocker. Current pharmaceutical design, 2003, Volume: 9, Issue:13 Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular System; Disease Model	2003
Non-genomic actions of aldosterone: mechanisms and consequences in kidney cells. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, Volume: 18, Issue:9 Topics: Aldosterone; Animals; Humans; Kidney; Kidney Diseases; Potassium; Receptors, Mineralocorticoid; Sodi	2003
Aldosterone in chronic kidney and cardiac disease. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:9 Topics: Aldosterone; Chronic Disease; Heart Diseases; Humans; Kidney Diseases	2003
RAAS escape: a real clinical entity that may be important in the progression of cardiovascular and renal disease. Current hypertension reports, 2003, Volume: 5, Issue:5 Topics: Aldosterone; Cardiovascular Diseases; Eplerenone; Humans; Kidney Diseases; Mineralocorticoid Recepto	2003
ALDOSTERONISM. Disease-a-month : DM, 1964, Volume: 45 Topics: Aldosterone; Diagnosis, Differential; Diuretics; Humans; Hyperaldosteronism; Hypertension; Kidney Di	1964
Aldosterone in the development and progression of renal injury. Kidney international, 2004, Volume: 66, Issue:1 Topics: Aldosterone; Animals; Disease Progression; Humans; Kidney Diseases	2004
Role of aldosterone blockade in the management of hypertension and cardiovascular disease. Contributions to nephrology, 2004, Volume: 143 Topics: Aldosterone; Animals; Heart Failure; Humans; Hypertension; Kidney Diseases; Mineralocorticoid Recept	2004
Aldosterone and renal injury. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2004, Volume: 124, Issue:2 Topics: Aldosterone; Animals; Kidney Diseases; Mineralocorticoid Receptor Antagonists; Rats	2004
Aldosterone and end-organ damage. Current opinion in nephrology and hypertension, 2005, Volume: 14, Issue:3 Topics: Aldosterone; Cardiovascular Diseases; Fibrosis; Humans; Kidney Diseases; Mineralocorticoid Receptor	2005
Adverse cardiorenal effects of aldosterone: is aldosterone antagonism beneficial? Expert review of cardiovascular therapy, 2005, Volume: 3, Issue:3 Topics: Aldosterone; Animals; Cardiovascular Diseases; Humans; Kidney Diseases; Mineralocorticoid Receptor A	2005
[Roll of aldosterone in pathogenesis of kidney disorders]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Jul-10, Volume: 94, Issue:7 Topics: Aldosterone; Animals; Body Water; Disease Models, Animal; Eplerenone; Humans; Hypertension; Kidney D	2005
Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade. Journal of pharmacological sciences, 2006, Volume: 100, Issue:1 Topics: Aldosterone; Animals; Cell Proliferation; Cell Shape; Cells, Cultured; Collagen; Eplerenone; Fibrobl	2006
Aldosterone and its blockade: a cardiovascular and renal perspective. TheScientificWorldJournal, 2006, Apr-03, Volume: 6 Topics: Aldosterone; Cardiovascular Physiological Phenomena; Heart Diseases; Humans; Kidney; Kidney Diseases	2006
Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade. Nature clinical practice. Nephrology, 2007, Volume: 3, Issue:1 Topics: Aldosterone; Humans; Kidney Diseases; Mineralocorticoid Receptor Antagonists	2007
Metabolic alkalosis, bedside and bench. Seminars in nephrology, 2006, Volume: 26, Issue:6 Topics: Aldosterone; Alkalosis; Angiotensins; Animals; Biological Transport; Disease Progression; Endothelin	2006
Ca2+ channel subtypes and pharmacology in the kidney. Circulation research, 2007, Feb-16, Volume: 100, Issue:3 Topics: Aldosterone; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Calcium Channel Blockers;	2007
Nongenomic actions of aldosterone on the renal tubule. Hypertension (Dallas, Tex. : 1979), 2007, Volume: 49, Issue:4 Topics: Aldosterone; Animals; Carrier Proteins; Genome; Humans; Ion Transport; Kidney; Kidney Diseases; Kidn	2007
New insights into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. American journal of physiology. Renal physiology, 2007, Volume: 293, Issue:1 Topics: Aldosterone; Animals; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Diseases	2007
Aldosterone and end-organ damage. Clinical science (London, England : 1979), 2007, Volume: 113, Issue:6 Topics: Aldosterone; Cardiovascular Diseases; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney; Kidn	2007
Aldosterone antagonism in chronic kidney disease. Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:4 Topics: Aldosterone; Animals; Chronic Disease; Humans; Kidney Diseases; Kidney Failure, Chronic; Mineralocor	2006
Aldosterone and progression of renal disease. Current opinion in nephrology and hypertension, 2008, Volume: 17, Issue:1 Topics: Aldosterone; Animals; Disease Progression; Humans; Hypertension; Kidney Diseases; Prorenin Receptor;	2008
Is kidney injury a reversible process? Current opinion in nephrology and hypertension, 2008, Volume: 17, Issue:1 Topics: Aldosterone; Animals; Extracellular Matrix; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors;	2008
Clonidine and the kidney. Journal of cardiovascular pharmacology, 1980, Volume: 2 Suppl 1 Topics: Adrenal Gland Neoplasms; Aldosterone; Antihypertensive Agents; Catecholamines; Clonidine; Humans; Hy	1980
[The renin-angiotensin system. Physiopathological aspects and clinical implications of hypertensive syndromes. A survey]. Minerva medica, 1981, Mar-31, Volume: 72, Issue:12 Topics: Acromegaly; Aldosterone; Angiotensin I; Angiotensin II; Captopril; Cushing Syndrome; Glycoproteins;	1981
Disorders of distal nephron function. The American journal of medicine, 1982, Volume: 72, Issue:2 Topics: Acidosis, Renal Tubular; Aldosterone; Bartter Syndrome; Bicarbonates; Biological Transport; Chloride	1982
Enzymatic disorders and hypertension. Clinics in endocrinology and metabolism, 1981, Volume: 10, Issue:3 Topics: Adrenal Hyperplasia, Congenital; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; A	1981
Acid-base disorders and the kidney. Advances in pediatrics, 1983, Volume: 30 Topics: Acid-Base Equilibrium; Acid-Base Imbalance; Acidosis; Acidosis, Renal Tubular; Aldosterone; Alkalosi	1983
Sodium and hypertension. A review of the role of sodium in pathogenesis and the action of diuretic drugs. Pharmacology & therapeutics, 1980, Volume: 9, Issue:3 Topics: Age Factors; Aldosterone; Amiloride; Benzothiadiazines; Diuretics; Furosemide; Humans; Hypertension;	1980
Potassium handling by the kidney. Hyperkalaemia. Australian and New Zealand journal of medicine, 1981, Volume: 11, Issue:Suppl 1 Topics: Acid-Base Equilibrium; Aldosterone; Animals; Humans; Hyperkalemia; Intracellular Fluid; Kidney Disea	1981
Clinical disorders of hyperkalemia. Annual review of medicine, 1982, Volume: 33 Topics: Acid-Base Imbalance; Addison Disease; Adrenal Hyperplasia, Congenital; Adult; Aged; Aldosterone; Cat	1982
Renal parenchymal disease and hypertension. Seminars in nephrology, 1995, Volume: 15, Issue:2 Topics: Aldosterone; Animals; Blood Proteins; Cardenolides; Digoxin; Endothelins; Humans; Hypertension; Kall	1995
Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors. The American journal of the medical sciences, 1994, Volume: 307 Suppl 1 Topics: Adrenal Glands; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hyperkalemia	1994
Renal adaptation to the failing heart. Understanding the cascade of responses. Postgraduate medicine, 1994, Volume: 95, Issue:8 Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Fac	1994
Aldosterone is a major factor in the progression of renal disease. Kidney international. Supplement, 1997, Volume: 63 Topics: Aldosterone; Animals; Disease Progression; Humans; Kidney Diseases; Renin-Angiotensin System; Risk F	1997
[Polymorphism of the renin-angiotensin-aldosterone system: molecular and epidemiogenetic aspects]. Nephrologie, 1998, Volume: 19, Issue:7 Topics: Aldosterone; Angiotensinogen; Cardiovascular Diseases; Genotype; Humans; Kidney Diseases; Peptidyl-D	1998
[11 beta-hydroxysteroid dehydrogenases: key enzymes in the action of mineralocorticoids and glucocorticoids]. Deutsche medizinische Wochenschrift (1946), 1999, Jan-22, Volume: 124, Issue:3 Topics: 11-beta-Hydroxysteroid Dehydrogenases; ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; A	1999
Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology. Kidney international, 2000, Volume: 57, Issue:4 Topics: Aldosterone; Animals; Cardiovascular Diseases; Drug Industry; Edema; Humans; Kidney Diseases; Minera	2000
Aldosterone in renal disease. Current opinion in nephrology and hypertension, 2001, Volume: 10, Issue:1 Topics: Aldosterone; Animals; Hyperaldosteronism; Kidney Diseases; Renal Insufficiency	2001
[Plasminogen activator inhibitor type 1: physiology and role in renal physiopathology]. Nephrologie, 2001, Volume: 22, Issue:1 Topics: Aldosterone; Fibrinolysis; Fibrosis; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Plasmi	2001
Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift. Journal of hypertension, 2001, Volume: 19, Issue:5 Topics: Aldosterone; Animals; Disease Progression; Humans; Hypertension; Kidney; Kidney Diseases; Renal Insu	2001
Aldosterone as a determinant of cardiovascular and renal dysfunction. Journal of the Royal Society of Medicine, 2001, Volume: 94, Issue:8 Topics: Aldosterone; Angiotensin II; Animals; Cardiovascular Diseases; Endothelium, Vascular; Fibrosis; Huma	2001
Pathophysiological effects of aldosterone in cardiovascular tissues. Trends in endocrinology and metabolism: TEM, 2001, Volume: 12, Issue:7 Topics: Adrenalectomy; Aldosterone; Animals; Cardiovascular Diseases; Cerebral Hemorrhage; Humans; Hypertens	2001
Aldosterone in progressive renal disease. Seminars in nephrology, 2001, Volume: 21, Issue:6 Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Humans; Hyperaldoste	2001
Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2000, Volume: 1, Issue:3 Topics: Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Ca	2000
The renin-angiotensin-aldosterone system in parenchymal kidney disease. Advances in nephrology from the Necker Hospital, 1975, Volume: 5 Topics: Acute Kidney Injury; Adrenal Glands; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Blood	1975
[Pure hypoaldosteronism in the adult]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1975, Volume: 20, Issue:2 Topics: Adrenal Glands; Adrenal Insufficiency; Adult; Aged; Aldosterone; Angiotensin II; Child; Glucocortico	1975
[Pathophysiological aspects of the renin-angiotensin-aldosterone system]. Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1977, Volume: 43 Topics: Adrenal Insufficiency; Aldosterone; Angiotensin II; Bartter Syndrome; Contraceptives, Oral; Half-Lif	1977
Renal effects of head-out water immersion in man: implications for an understanding of volume homeostasis. Physiological reviews, 1978, Volume: 58, Issue:3 Topics: Acid-Base Equilibrium; Aldosterone; Angiotensin II; Animals; Blood Volume; Catecholamines; Diuresis;	1978
[Structural foundation for the functional connections of the endocrine apparatus and nervous system of the kidneys]. Arkhiv patologii, 1978, Volume: 40, Issue:11 Topics: Aldosterone; Angiotensin II; Endocrine Glands; Humans; Juxtaglomerular Apparatus; Kidney; Kidney Cor	1978
[Isolated hypoaldosteronism in adults. Role of diabetes]. Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1979, Volume: 24, Issue:5 Topics: Aldosterone; Diabetes Complications; Fludrocortisone; Humans; Hyperkalemia; Kidney Diseases; Renin;	1979
[Renal hypertension]. Schweizerische medizinische Wochenschrift, 1976, Dec-11, Volume: 106, Issue:50 Topics: Aldosterone; Angiotensin II; Diuretics; Furosemide; Glomerulonephritis; Humans; Hypercalcemia; Hyper	1976
Renal consequences of valvular heart disease. The American journal of cardiology, 1975, Volume: 35, Issue:6 Topics: Aldosterone; Angiocardiography; Contrast Media; Diuresis; Diuretics; Drug Hypersensitivity; Edema; E	1975
[Pathophysiology of renal hypertension (author's transl)]. Der Radiologe, 1975, Volume: 15, Issue:4 Topics: Aldosterone; Angiotensin II; Arteriosclerosis; Blood Pressure; Catecholamines; Child; Extracellular	1975
Adverse effects of beta-adrenoceptor antagonists on the kidney. Adverse drug reactions and acute poisoning reviews, 1985,Spring, Volume: 4, Issue:1 Topics: Adrenergic beta-Antagonists; Aldosterone; Drug Interactions; Glomerular Filtration Rate; Humans; Kid	1985
[Advances in research on the relation between the kidney and the ear]. Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, 1985, Volume: 5, Issue:9 Topics: Aldosterone; Animals; Anti-Bacterial Agents; Bone Diseases; Ear; Ear, Inner; Hearing Disorders; Huma	1985
Primary acquired hypoaldosteronism. Kidney international, 1985, Volume: 27, Issue:4 Topics: Absorption; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Biological Transport, Active;	1985
Hyperkalemia. Advances in internal medicine, 1986, Volume: 31 Topics: Acid-Base Equilibrium; Aldosterone; Arrhythmias, Cardiac; Heart Block; Humans; Hyperkalemia; Insulin	1986
Sickle cell nephropathy: new insights into its pathophysiology. Kidney international, 1985, Volume: 27, Issue:5 Topics: Aldosterone; Anemia, Sickle Cell; Hemodynamics; Humans; Indomethacin; Kidney Diseases; Kidney Medull	1985
[Hypertensive syndrome in kidney diseases]. Klinicheskaia meditsina, 1985, Volume: 63, Issue:4 Topics: Aldosterone; Blood Pressure; Blood Volume; Diagnosis, Differential; Diuresis; Humans; Hyperaldostero	1985
[Activity of renin-angiotensin in normal and abnormal conditions]. Saishin igaku. Modern medicine, 1967, Volume: 22, Issue:5 Topics: Adrenal Gland Diseases; Aldosterone; Angiotensin II; Humans; Hypertension; Kidney; Kidney Diseases;	1967
Control of aldosterone secretion by the renin-angiotensin system and by corticotropin. Advances in internal medicine, 1968, Volume: 14 Topics: Addison Disease; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Animals; Female; Humans;	1968
[Renovascular hypertension in pregnancy]. Naika. Internal medicine, 1969, Volume: 24, Issue:4 Topics: Aldosterone; Angiotensin II; Blood Pressure; Chronic Disease; Female; Humans; Hypertension, Renal; K	1969
[The renin--angiotensin--aldosterone system]. Kardiologiia, 1969, Volume: 9, Issue:9 Topics: Adrenal Cortex Hormones; Aldosterone; Angiotensin II; Animals; Arteries; Blood Pressure; Blood Volum	1969
Pre-eclampsia and related complications of pregnancy. American journal of obstetrics and gynecology, 1970, May-01, Volume: 107, Issue:1 Topics: Adult; Aldosterone; Angiotensin II; Blood Coagulation Disorders; Catecholamines; Diagnosis, Differen	1970
The relationship between angiotensin and aldosterone. Advances in metabolic disorders, 1971, Volume: 5 Topics: Adrenal Gland Neoplasms; Aldosterone; Alkalosis; Angiotensin II; Animals; Humans; Hyperaldosteronism	1971
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. The American journal of medicine, 1972, Volume: 52, Issue:5 Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Aldosterone; Angiotensin II; Contraceptives, Oral;	1972
The physiology of renin. Archives of internal medicine, 1973, Volume: 131, Issue:6 Topics: Aldosterone; Angiotensin II; Edema; Extracellular Space; Female; Glomerular Filtration Rate; Humans;	1973
Anaesthesia, surgery and renal function: immediate and delayed effects. Anaesthesia and intensive care, 1973, Volume: 1, Issue:5 Topics: Aldosterone; Anesthesia, Inhalation; Anesthetics; Angiotensin II; Animals; Dose-Response Relationshi	1973
The pathophysiology of renin. Clinical symposia (Summit, N.J. : 1957), 1973, Volume: 25, Issue:5 Topics: Aldosterone; Angiotensin II; Animals; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renal;	1973
[Clinical syndromes of renal sodium loss]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1972, Feb-28, Volume: 27, Issue:9 Topics: Adrenal Glands; Aldosterone; Feedback; Glomerular Filtration Rate; Humans; Hyponatremia; Kidney; Kid	1972
Renin and hypertension: a review article. The Central African journal of medicine, 1973, Volume: 19, Issue:4 Topics: Aldosterone; Humans; Hydrochlorothiazide; Hypertension; Juxtaglomerular Apparatus; Kidney Diseases;	1973
Renal regulation of sodium excretion. Function in health and in edema-forming states. Archives of internal medicine, 1973, Volume: 131, Issue:6 Topics: Aldosterone; Colloids; Edema; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Kidney Dise	1973
Hereditary disorders of the kidney. II. Hereditary nephropathies. Perspectives in pediatric pathology, 1973, Volume: 1 Topics: Adolescent; Adult; Aldosterone; Amyloidosis; Bone Resorption; Child; Child, Preschool; Female; Glome	1973
[Dynamics of water and sodium in renal insufficiency: in reference to therapeutic classification of disease stages]. Nihon rinsho. Japanese journal of clinical medicine, 1974, Volume: 32, Issue:3 Topics: Adolescent; Adult; Aldosterone; Diuretics; Furosemide; Humans; Kidney Concentrating Ability; Kidney	1974
Primary hyperaldosteronism. Clinics in endocrinology and metabolism, 1974, Volume: 3, Issue:3 Topics: Adrenal Gland Neoplasms; Aldosterone; Corticosterone; Desoxycorticosterone; Electrocardiography; Hum	1974
[Advances in physiopathology]. Polskie Archiwum Medycyny Wewnetrznej, 1967, Volume: 38, Issue:6 Topics: Acidosis, Respiratory; Aldosterone; Alkalosis; Humans; Hyponatremia; Kidney Diseases; Metabolic Dise	1967
Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): a re-evaluation of the pathophysiology. Medicine, 1968, Volume: 47, Issue:2 Topics: Acid-Base Equilibrium; Adolescent; Adult; Aldosterone; Child; Child, Preschool; Female; Humans; Hype	1968
[Recent knowledge of diseases with abnormal aldosterone secretion]. Naika hokan. Japanese archives of internal medicine, 1971, Volume: 18, Issue:1 Topics: Addison Disease; Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Aldosterone; A	1971
Edema and pulmonary edema: pathologic physiology and differential diagnosis. Progress in cardiovascular diseases, 1971, Volume: 13, Issue:6 Topics: Adrenal Glands; Aldosterone; Diagnosis, Differential; Edema; Extracellular Space; Female; Heart Dise	1971
[The third factor]. Naika. Internal medicine, 1971, Volume: 28, Issue:1 Topics: Aldosterone; Animals; Biological Assay; Dogs; Extracorporeal Circulation; Female; Glomerular Filtrat	1971

Article	Year
Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 52, Issue:3 Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Chemokine CCL2;	2008
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure. American journal of physiology. Renal physiology, 2003, Volume: 284, Issue:5 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Cross-Over Studies; Diuretics; Double	2003
Combined converting enzyme inhibition and angiotensin receptor blockade reduce proteinuria greater than converting enzyme inhibition alone: insights into mechanism. Clinical nephrology, 2003, Volume: 60, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Disease Progr	2003
Synthetic human alpha-atrial natriuretic peptide improves the management of postoperative hypertension and renal dysfunction after the repair of abdominal aortic aneurysm. Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:5 Topics: Aged; Aldosterone; Aortic Aneurysm, Abdominal; Atrial Natriuretic Factor; Chi-Square Distribution; F	2003
Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment. International journal of clinical pharmacology and therapeutics, 2005, Volume: 43, Issue:9 Topics: Aged; Aged, 80 and over; Albuminuria; Aldosterone; Anti-Inflammatory Agents, Non-Steroidal; Creatini	2005
Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. Clinical nephrology, 1981, Volume: 16, Issue:2 Topics: Adolescent; Adult; Aldosterone; Captopril; Child; Clinical Trials as Topic; Female; Humans; Hyperten	1981
Haemodynamic and metabolic effects of carbenoxolone in normal subjects and patients with renal impairment. Clinical and experimental hypertension (New York, N.Y. : 1993), 1994, Volume: 16, Issue:4 Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adult; Aldosterone; Blood Vessels; Body Weight; Carbenoxolone	1994
Efficacy of manidipine in the treatment of hypertension with renal impairment: a multicenter trial. American heart journal, 1993, Volume: 125, Issue:2 Pt 2 Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Antihypertensive Agents; Blood Urea Nitrogen; Calcium C	1993
Effect of metoclopramide on dopamine-induced changes in renal function in healthy controls and in patients with renal disease. Clinical science (London, England : 1979), 1988, Volume: 75, Issue:4 Topics: Adult; Aldosterone; beta 2-Microglobulin; Blood Pressure; Dopamine Antagonists; Dose-Response Relati	1988
Side effects of cyclosporin A treatment in patients with rheumatoid arthritis. Kidney international, 1986, Volume: 29, Issue:6 Topics: Albuminuria; Aldosterone; Arthritis, Rheumatoid; Azathioprine; beta 2-Microglobulin; Blood Pressure;	1986

aldosterone and Kidney Diseases

Research Excerpts

Research

Studies (373)

Authors

Clinical Trials (6)

Trial Overview

Reviews

Trials

Other Studies

Authors	Studies
Kolkhof, P	1
Joseph, A	1
Kintscher, U	1
Clarisse, D	1
Deng, L	1
de Bosscher, K	1
Lother, A	1
Faour, WH	1
Choaib, A	1
Issa, E	1
Choueiry, FE	1
Shbaklo, K	1
Alhajj, M	1
Sawaya, RT	1
Harhous, Z	1
Alefishat, E	1
Nader, M	1
Zhu, X	1
Gao, D	1
Albertazzi, V	1
Zhong, J	1
Ma, LJ	2
Du, L	1
Shyr, Y	1
Kon, V	1
Yang, HC	1
Fogo, AB	3
Nakamura, T	1
Bonnard, B	1
Palacios-Ramirez, R	1
Fernández-Celis, A	1
Jaisser, F	6
López-Andrés, N	1
Asakawa, M	1
Takagi, N	1
Hamada, D	1
Yamasaki, Y	1
Takaku, Y	1
Kawada, M	1
Murata, T	1
Katsuta, H	1
Gao, X	1
Chang, J	1
Chang, Y	1
Fan, L	1
Liu, Z	1
Zhang, C	2
Shimosawa, T	2
Yang, F	1
Xu, Q	2
Hajal, J	1
Joubran, N	1
Sleilaty, G	1
Chacra, D	1
Saliba, Y	1
Assaad, S	1
Chelala, D	1
Fares, N	1
Barrera-Chimal, J	1
Williams, GH	1
Rotem-Grunbaum, B	1
Landau, D	1
Gupta, G	1
Dahiya, R	1
Singh, Y	1
Mishra, A	1
Verma, A	2
Gothwal, SK	1
Aljabali, AAA	1
Dureja, H	1
Prasher, P	1
Negi, P	1
Kapoor, DN	1
Goyal, R	1
Tambuwala, MM	1
Chellappan, DK	1
Dua, K	1
Leader, CJ	1
Kelly, DJ	1
Sammut, IA	1
Wilkins, GT	1
Walker, RJ	2
Zheng, W	1
Ocorr, K	1
Tatar, M	1
Liu, Y	1
Lin, Y	1
Zhang, MM	1
Li, XH	1
Liu, YY	1
Zhao, J	1
Shi, L	2
Schmidt, IM	1
Waikar, SS	1
Papadimitriou, A	1
Romagnani, P	1
Angelotti, ML	1
Noor, M	1
Corcoran, J	1
Raby, K	1
Wilson, PD	1
Li, J	1
Fraser, D	1
Piedagnel, R	1
Hendry, BM	1
Hundemer, GL	1
Vaidya, A	1
Zhao, C	2
Wang, H	3
Lei, T	1
Liu, S	1
Cao, J	1
Lu, Z	1
Yuan, Y	6
Zhang, A	7
Qi, J	1
Liu, X	1
Zhao, M	3
Duan, S	1
Huang, Z	1
Wu, L	1
Zhang, B	2
Xing, C	2
Park, EJ	1
Jung, HJ	1
Choi, HJ	1
Cho, JI	1
Park, HJ	1
Kwon, TH	1
Ding, W	3
Liu, T	1
Bi, X	1
Zhang, Z	1
Taguchi, K	1
Yamagishi, SI	1
Yokoro, M	1
Ito, S	1
Kodama, G	1
Kaida, Y	1
Nakayama, Y	1
Ando, R	1
Yamada-Obara, N	1
Asanuma, K	1
Matsui, T	1
Higashimoto, Y	1
Brooks, CR	1
Ueda, S	1
Okuda, S	1
Fukami, K	1
Zhang, YD	1
Ding, XJ	1
Dai, HY	1
Peng, WS	1
Guo, NF	1
Zhang, Y	1
Zhou, QL	1
Chen, XL	1
Li, Y	2
Wang, X	1
Zhang, L	1
Yuan, X	1
Hao, J	1
Ni, J	1
Hao, L	1
Ames, MK	1
Atkins, CE	1
Pitt, B	1
Balakumar, P	1
Sambathkumar, R	1
Mahadevan, N	1
Muhsinah, AB	1
Alsayari, A	1
Venkateswaramurthy, N	1
Jagadeesh, G	1
Kawashima, A	1
Sone, M	1
Inagaki, N	1
Takeda, Y	1
Itoh, H	3
Kurihara, I	1
Umakoshi, H	1
Ichijo, T	1
Katabami, T	1
Wada, N	1
Ogawa, Y	1
Kawashima, J	1
Fujita, M	1
Miyauchi, S	1
Okamura, S	1
Fukuoka, T	1
Yanase, T	1
Izawa, S	1
Yoshikawa, Y	1
Hashimoto, S	1
Yamada, M	1
Kai, T	1
Suzuki, T	2
Naruse, M	1
Alvarez de la Rosa, D	1
Navarro-González, JF	1
Giraldez, T	1
Su, M	1
Dhoopun, AR	1
Huang, S	4
Zhu, C	3
Ding, G	4
Liu, B	3
Yang, T	3
Nugrahaningsih, DA	1
Emoto, N	1
Vignon-Zellweger, N	1
Purnomo, E	1
Yagi, K	1
Nakayama, K	1
Doi, M	1
Okamura, H	2
Hirata, K	1
Young, MJ	1
Fuller, PJ	1
Stowasser, M	2
Mihailidou, AS	1
Hu, Q	1
Yin, L	1
Hartmann, RW	1
Homma, K	2
Hayashi, K	2
Yamaguchi, S	1
Fujishima, S	1
Hori, S	1
Cooper, DL	1
Murrell, DE	1
Conder, CM	1
Palau, VE	1
Campbell, GE	1
Lynch, SP	1
Denham, JW	1
Hanley, AV	1
Bullins, KW	1
Panus, PC	1
Singh, K	1
Harirforoosh, S	1
Hannemann, A	2
Rettig, R	2
Dittmann, K	1
Völzke, H	2
Endlich, K	1
Nauck, M	2
Wallaschofski, H	2
Xu, C	2
Yang, L	1
Yang, M	1
Zhang, M	1
Gu, Y	2
Doi, T	1
Doi, S	1
Nakashima, A	1
Ueno, T	1
Yokoyama, Y	1
Kohno, N	1
Masaki, T	1
Yu, AS	1
Bakris, GL	2
Bauersachs, J	1
Toto, R	2
Lieb, W	1
Chen, MH	1
Teumer, A	1
de Boer, RA	2
Lin, H	1
Fox, ER	1
Musani, SK	1
Wilson, JG	1
Wang, TJ	1
Petersen, AK	1
Meisinger, C	1
Schlesinger, S	1
Menard, J	1
Hercberg, S	1
Wichmann, HE	1
Völker, U	1
Rawal, R	1
Bidlingmaier, M	1
Dörr, M	1
van Gilst, WH	2
van Veldhuisen, DJ	1
Bakker, SJ	1
Navis, G	3
Meneton, P	1
van der Harst, P	1
Reincke, M	1
Vasan, RS	1
Sun, QL	1
Li, M	1
Rui, HL	1
Chen, YP	1
Brem, AS	3
Gong, R	1
Butterworth, MB	1
Sawada, H	1
Naito, Y	1
Oboshi, M	1
Iwasaku, T	1
Okuhara, Y	1
Morisawa, D	1
Eguchi, A	1
Hirotani, S	1
Masuyama, T	1
Kadoya, H	1
Satoh, M	1
Sasaki, T	1
Taniguchi, S	1
Takahashi, M	1
Kashihara, N	1
Xu, X	1
Wang, N	1
Mao, H	1
Farman, N	1
Buglioni, A	1
Cannone, V	1
Sangaralingham, SJ	1
Heublein, DM	1
Scott, CG	1
Bailey, KR	1
Rodeheffer, RJ	1
Sarzani, R	1
Burnett, JC	2
Martín-Fernández, B	1
Rubio-Navarro, A	1
Cortegano, I	1
Ballesteros, S	1
Alía, M	1
Cannata-Ortiz, P	1
Olivares-Álvaro, E	1
Egido, J	1
de Andrés, B	1
Gaspar, ML	1
de Las Heras, N	1
Lahera, V	2
Moreno, JA	1
Bernhardt, R	1
Bai, M	1
Jia, Z	1
Jakes, AD	1
Baynes, K	1
Nelson-Piercy, C	1
Noilhan, C	1
Barigou, M	1
Bieler, L	1
Amar, J	1
Chamontin, B	1
Bouhanick, B	1
Tanino, A	1
Okura, T	1
Nagao, T	1
Kukida, M	1
Pei, Z	1
Enomoto, D	1
Miyoshi, K	1
Higaki, J	1
Guo, H	1
Li, H	1
Ling, L	1
Wolf, G	1
Ruilope, LM	1
Lin, SL	1
Chen, YM	1
Chiang, WC	1
Wu, KD	1
Tsai, TJ	1
Major, TC	1
Olszewski, B	1
Rosebury, W	1
Okerberg, C	1
Carlson, T	1
Ostroski, R	1
Schroeder, R	1
Kowala, MC	1
Leadley, R	1
Bomback, AS	4
Klemmer, PJ	3
Sechi, LA	2
Novello, M	1
Colussi, G	4
Di Fabio, A	1
Chiuch, A	2
Nadalini, E	2
Casanova-Borca, A	1
Uzzau, A	1
Catena, C	2
Kiyomoto, H	2
Rafiq, K	2
Mostofa, M	1
Nishiyama, A	5
Brown, NJ	4
Gaddam, KK	1
Pimenta, E	3
Husain, S	1
Calhoun, DA	3
Cortinovis, M	1
Perico, N	1
Cattaneo, D	1
Remuzzi, G	1
Nardi, E	1
Palermo, A	1
Mulè, G	1
Cusimano, P	1
Cottone, S	1
Cerasola, G	1
Hammer, F	1
Stewart, PM	1
van den Hoven, MJ	1
Waanders, F	1
Rops, AL	1
Kramer, AB	1
van Goor, H	2
Berden, JH	1
van der Vlag, J	1
Kooter, AJ	1
Smulders, YM	1
Sowers, JR	2
Whaley-Connell, A	1
Epstein, M	6
Becker, GJ	1
Hewitson, TD	1
Chrysostomou, A	1
Andoh, D	1
Yasuda, G	1
Umemura, S	1
Fan, YY	1
Kohno, M	1
Nakano, D	2
Hitomi, H	2
Nagai, Y	1
Fujisawa, Y	1
Lu, XM	1
Fu, H	1
Du, J	1
Ohmori, K	1
Hosomi, N	1
Kimura, S	1
Ramírez, V	3
Trujillo, J	1
Valdes, R	1
Uribe, N	3
Cruz, C	2
Gamba, G	4
Bobadilla, NA	4
Jain, G	1
Campbell, RC	1
Warnock, DG	2
Arias-Loza, PA	1
Muehlfelder, M	1
Elmore, SA	1
Maronpot, R	1
Hu, K	1
Blode, H	1
Hegele-Hartung, C	1
Fritzemeier, KH	1
Ertl, G	1
Pelzer, T	1
Vogt, B	1
Burnier, M	1
Mizuguchi, Y	1
Ichihara, A	1
Seki, Y	1
Sakoda, M	1
Kurauchi-Mito, A	1
Narita, T	1
Kinouchi, K	1
Bokuda, K	1
Nagase, M	6
Fujita, T	3
Toto, RD	1
Maksimov, ML	1
Ryu, HH	1
Kim, HL	1
Chung, JH	1
Lee, BR	1
Kim, TH	1
Shin, BC	1
Takano, K	1
Kawasaki, Y	1
Imaizumi, T	1
Ohara, S	1
Takeyama, A	1
Suyama, K	1
Hashimoto, K	1
Hosoya, M	1
Sahni, V	1
Rosa, RM	2
Batlle, D	1
Bertocchio, JP	2
Tomaschitz, A	1
Pilz, S	1
Ritz, E	1
Grammer, T	1
Drechsler, C	1
Boehm, BO	1
März, W	1
Dooley, R	1
Harvey, BJ	1
Thomas, W	1
Seyberth, HW	1
Schlingmann, KP	1
Chen, R	1
Balavoine, AS	1
Bataille, P	1
Vanhille, P	1
Azar, R	1
Noël, C	1
Asseman, P	1
Soudan, B	1
Wémeau, JL	1
Vantyghem, MC	1
Shibata, S	2
Mu, S	1
Kawarazaki, H	1
Muraoka, K	1
Ishizawa, K	1
Yoshida, S	1
Kawarazaki, W	1
Takeuchi, M	1
Ayuzawa, N	1
Miyoshi, J	1
Takai, Y	1
Ishikawa, A	1
Ando, K	1
Li, SW	1
Hu, LJ	1
Wu, QH	1
Huang, P	1
Cao, HY	1
Kim-Mitsuyama, S	1
Fourkiotis, VG	1
Hanslik, G	1
Hanusch, F	1
Lepenies, J	1
Quinkler, M	2
Baracco, R	1
Kapur, G	1
Mattoo, T	1
Jain, A	1
Valentini, R	1
Ahmed, M	2
Thomas, R	1
Queisser, N	1
Schupp, N	1
Luther, JM	1
Luo, P	1
Wang, Z	1
Cohen, SE	1
Kim, HS	1
Wang, W	2
Wang, Y	1
Zhang, P	2
Gordon, RD	1
Tsuruoka, S	1
Hiwatashi, A	1
Usui, J	1
Yamagata, K	1
Fouad, AA	1
Al-Mulhim, AS	1
Jresat, I	1
Morsy, MA	1
Weber, MA	1
Feria, I	1
Pichardo, I	1
Juárez, P	1
González, MA	1
García-Torres, R	1
López-Casillas, F	1
Ullian, ME	1
Gantt, BJ	1
Ford, AK	1
Tholanikunnel, BG	1
Spicer, EK	1
Fitzgibbon, WR	1
Wang, DH	1
Zhao, Y	1
Ibrahim, HN	5
Hostetter, TH	7
Rossier, BC	1
Chen, HH	1
Redfield, MM	1
Nordstrom, LJ	1
Cataliotti, A	1
McMahon, EG	1
Panos, J	1
Michelis, MF	1
DeVita, MV	1
Lavie, RH	1
Wilkes, BM	1
Boldyreff, B	1
Wehling, M	2
Lakkis, J	1
Lu, WX	1
Weir, MR	1
Kellner, M	1
Peiter, A	1
Hafner, M	1
Feuring, M	1
Christ, M	1
Falkenstein, E	1
Lösel, R	1
PETERSEN, VP	1
PACOVSKY, V	2
KOMARKOVA, A	1
MOTLIK, K	1
NADASDI, M	1
MANNING, RT	1
BEHRLE, FC	1
BORKOVICH, KH	1
DUBOVSKY, J	1
DUBOVSKA, E	1
KUECHEL, O	1
FLEISHMAN, SJ	1
SENIOR, B	1
SUZMAN, MM	1
ARROYO, H	1
BERNARD, A	1
GOWENLOCK, AH	1
WRONG, O	1
TAHBASIAN, M	1
ROYER, P	1
BONNETTE, J	1
MATHIEU, H	1
GABILAN, JC	1
KLUTCHKO, G	1
ZITTOUN, R	1
MULROW, PJ	1
LUETSCHER, JA	1
DENTON, DA	1
BRYAN, GT	1
KLIMAN, B	1
GILL, JR	1
BARTTER, FC	1
BURY, HP	1
CRANE, WA	1
DUTTA, LP	1
WALKER, WG	2
JOST, LJ	1
JOHNSON, JR	1
KOWARSKI, A	2
JAKOBSON, T	1
Yang, H	1
Gaspert, A	1
Carlesso, G	1
Barty, MM	1
Davidson, JM	1
Sheppard, D	1
Hayashi, Y	1
Ohtani, M	1
Sawa, Y	1
Hiraishi, T	1
Akedo, H	1
Kobayashi, Y	1
Matsuda, H	1
Oestreicher, EM	1
Martinez-Vasquez, D	1
Stone, JR	1
Jonasson, L	1
Roubsanthisuk, W	1
Mukasa, K	1
Adler, GK	1
Graebe, M	1
Brond, L	1
Christensen, S	1
Nielsen, S	1
Olsen, NV	1
Jonassen, TE	1
de Borst, MH	1
Huitema, S	1
Vis, LM	1
Hollenberg, NK	1
Abe, Y	2
Javadi, S	1
Djajadiningrat-Laanen, SC	1
Kooistra, HS	1
van Dongen, AM	1
Voorhout, G	1
van Sluijs, FJ	1
van den Ingh, TS	1
Boer, WH	1
Rijnberk, A	1
Michel, MC	1
Hahntow, I	1
Koopmans, RP	1
Coca, SG	1
Perazella, MA	1
Fiebeler, A	1
Nussberger, J	1
Shagdarsuren, E	1
Rong, S	1
Hilfenhaus, G	1
Al-Saadi, N	1
Dechend, R	1
Wellner, M	1
Meiners, S	1
Maser-Gluth, C	1
Jeng, AY	1
Webb, RL	1
Luft, FC	1
Muller, DN	1
Kitamura, K	1
Tomita, K	1
Horackova, M	1
Schück, O	1
Komers, R	1
Charvat, J	1
Teplan, V	1
Kvapil, M	1
Morris, RG	1
Hoorn, EJ	1
Knepper, MA	1
Cachofeiro, V	1
Balfagon, G	1
Rodicio, JL	1
Chappell, MC	1
Yamaleyeva, LM	1
Westwood, BM	1
Del Vecchio, L	1
Procaccio, M	1
Viganò, S	1
Cusi, D	1
Laski, ME	1
Sabatini, S	1
Wakino, S	1
Sugano, N	1
Ozawa, Y	1
Saruta, T	3
Good, DW	1
Mejía-Vilet, JM	1
Sun, XJ	1
Liu, SR	1
Zhang, CH	1
Yuan, GH	1
Chen, HY	1
Hou, XF	1
Tarry-Adkins, JL	1
Joles, JA	1
Chen, JH	1
Martin-Gronert, MS	1
van der Giezen, DM	1
Goldschmeding, R	1
Hales, CN	1
Ozanne, SE	1
Soltero, L	1
Huang, XR	1
Lan, HY	1
Adrogue, HJ	1
Diederich, S	2
Mai, K	1
Bähr, V	2
Helffrich, S	1
Pfeiffer, A	1
Perschel, FH	1
Marney, AM	1
Ponda, MP	1
Baroselli, S	1
Lapenna, R	1
Matsui, H	1
Gotoda, T	1
Wenzel, U	1
Chatziantoniou, C	1
Dussaule, JC	1
Huang, W	1
Kahng, KW	1
Noble, NA	1
Border, WA	1
Huang, Y	1
Minuth, WW	1
Denk, L	1
Castrop, H	1
Chun, TY	1
Chander, PN	1
Kim, JW	1
Pratt, JH	1
Stier, CT	2
Aarskog, D	1
Stoa, KF	1
Thorsen, T	1
Wefring, KW	1
Weidmann, P	8
Siegenthaler, W	3
Itskovitz, HD	1
Molinatti, GM	1
Limone, P	1
Paillard, J	1
Baviera, E	1
Agarwal, MK	1
Wauters, JP	1
Waeber, B	1
Brunner, HR	3
Guignard, JP	1
Turini, GA	1
Gavras, H	2
Sebastian, A	2
Hulter, HN	1
Kurtz, I	1
Maher, T	1
Schambelan, M	3
Biglieri, EG	3
Donckerwolcke, RA	1
Keszler, M	1
Sivasubramanian, KN	1
Levitan, D	1
Massry, SG	1
Romoff, M	1
Campese, VM	1
Rösler, A	1
Lowenstein, I	1
Alterman, L	1
Zelen, R	1
Bank, DE	1
Bank, N	1
Beretta-Piccoli, C	2
Schiffl, H	2
Reubi, FC	3
Chan, JC	1
Arruda, JA	1
Batlle, DC	2
Sehy, JT	1
Roseman, MK	1
Baronowski, RL	1
Kurtzman, NA	1
Ziegler, WH	1
Glück, Z	3
Meier, A	1
Keusch, G	2
DeFronzo, RA	2
Studer, A	1
Záruba, K	1
Grimm, J	1
Kuhlmann, U	1
Vetter, W	1
De Châtel, R	1
Cottier, C	1
Morgan, T	1
Carney, S	1
Myers, J	1
Hubl, W	1
Büchner, M	1
Barratt, LJ	1
Bia, M	1
Smith, D	1
Timins, JE	1
Hariprasad, MK	1
Knobel, B	1
Robson, M	1
Fryd, CH	1
Saidel, I	1
Kelijman, M	1
Garnacho de Vega, A	1
Romero González, R	1
Rey, C	1
Signoretti, A	1
Bacchetta, V	1
Cugini, P	1
Di Erasmo, A	1
Lombari, MR	1
Imperato, C	1
Nakagawa, K	1
Kanno, Y	1
Ichinoe, S	1
Toyozaki, N	1
Ito, T	1
Kawasaki, T	1
Nakamuta, S	1
Omae, T	1
Preston, RA	1
Whitworth, JA	1
Williamson, PM	1
Brown, MA	1
Edwards, CR	1
Rombolà, G	1
De Ferrari, ME	1
Macaluso, M	1
Minetti, L	1
Schlueter, W	1
Keilani, T	1
Riley, DJ	1
Weir, M	1
John, EG	1
Fornell, LC	1
Radhakrishnan, J	1
Anutrakulchai, S	1
Jonasson, O	1
Suzuki, H	1
Szylman, P	1
Benzakin, A	1
Szjnader, Y	1
Taitelman, U	1
Greene, EL	2
Kren, S	2
Cianciaruso, B	2
Bellizzi, V	1
Minutolo, R	1
Colucci, G	1
Bisesti, V	1
Russo, D	1
Conte, G	1
De Nicola, L	1
Rodríguez-Soriano, J	1
Vallo, A	1
Rosenberg, ME	3
Kano, H	1
Orita, S	1
Hirose, M	1
Kawano, M	1
Okamura, M	1
Tani, T	1
Minami, M	1
Yokokawa, A	1
Haraguchi, M	1
Yasunari, K	1
Yoshikawa, J	1
Soubrier, F	1
Hanke, B	1
Oelkers, W	2
Delyani, JA	1
Sun, Y	1
Zhang, J	1
Zhang, JQ	1
Ramires, FJ	1
Denolle, T	1
Hanon, O	1
Mounier-Vehier, C	1
Marquand, A	1
Fauvel, JP	1
Laurent, P	1
Tison, E	1
Equine, O	1
Ducloux, D	1
Girerd, X	1
Bettinelli, A	1
Consonni, D	1
Bianchetti, MG	1
Casari, G	1
Juknevicius, I	2
Rerolle, JP	1
Vigneau, C	1
Hertig, A	1
Berrou, J	1
Rondeau, E	1
Elisaf, M	1
Katopodis, K	1
Siamopoulos, KC	1
Rocha, R	1
Molteni, A	1
Moulder, JE	1
Cohen, EP	1
Fish, BL	1
Taylor, JM	1
Veno, PA	1
Wolfe, LF	1
Ward, WF	1
Weinberg, MS	1
Weinberg, AJ	1
Zappe, DH	1
Bistritzer, T	1
Kerem, E	1
Berkovitch, M	1
Rapoport, MJ	1
Evans, S	1
Aladjem, M	1
Maxwell, MH	1
Benoit, G	1
Rado, JP	1
Boer, P	1
Dorhout Mees, EJ	1
Simatupang, T	1
Serov, VV	1
Pal'tsev, MA	1
Stone, WJ	1
Heim, J	1
Sparano, F	1
Sciarra, F	1
Sulon, J	1
Giaquinto, G	1
Mercuri, MA	1
Odoardi, A	1
Tosticroce, C	1
Genard, P	1
Conti, C	1
McGrath, BP	1
Tiller, DJ	2
Bune, A	1
Chalmers, JP	1
Korner, PI	1
Uther, JB	1
Kahn, T	1
Kaji, DM	1
Nicolis, G	1
Krakoff, LR	2
Stein, RM	1
Seino, M	1
Bock, KD	1
Cremer, W	1
Werner, U	1
Levy, M	1
Hayashida, Y	1
Reubi, F	1
Werning, C	2
Thiele, KG	1
Kyank, H	1
Neumayer, E	1
During, R	1
Stegman, MR	1
Batterman, B	1
Fitz, A	1
Porter, GA	1
Bennett, WM	1
Wilson, JW	1
Cottier, P	1
Perez-Stable, EC	1
Materson, BJ	1
Dillon, MJ	2
Ryness, JM	1
Cecchettin, M	1
Albertini, A	1
Ghielmi, S	1
Signorini, C	1
Orlandini, A	1
Maiorca, R	1
Priest, JN	1
Nuttall, FQ	1
Berger, HH	1
Albert, FW	1
Shemer, J	1
Royburt, M	1
Cabili, S	1
Iaina, A	1
Pras, M	1
Eliahou, H	1
Guliev, ND	1
Lazarev, VV	1
Mukhin, VKh	1
Lenz, T	1
Müller, FB	1
Sotelo, JE	1
Laragh, JH	4
August, P	1
Ocón-Pujadas, J	1
Debusmann, ER	1
Jane, F	1
Lahn, W	1
Irmisch, R	1
Mora, J	1
Grötsch, H	1
Swainson, CP	1
Bailey, RR	1
Girolami, JP	1
Bascands, JL	1
Pécher, C	1
Cabos, G	1
Moatti, JP	1
Mercier, JF	1
Haguenoer, JM	1
Manuel, Y	1
Reams, GP	1
Lau, A	1
Bauer, JH	1
Fernandez-Seara, J	1
Prieto, J	1
Quiroga, J	1
Zozaya, JM	1
Cobos, MA	1
Rodriguez-Eire, JL	1
Garcia-Plaza, A	1
Leal, J	1
ter Borg, EJ	1
de Jong, PE	2
Meijer, S	2
Kallenberg, CG	1
Waller, DG	1
George, CF	1
Smit, AJ	1
Wesseling, H	1
Donker, AJ	1
Reitsma, WD	1
Yu, ZF	1
Eiskjaer, H	1
Pedersen, EB	1
Rasmussen, LM	1
Jespersen, B	1
Kater, CE	1
Rost, CR	1
Hirai, J	1
Chang, BC	1
Brust, N	1
Beck, FW	1
Waters, BK	1
Barrett, JD	1
Welch, BG	1
Kokko, JP	1
Cobden, I	1
Shore, A	1
Wilkinson, R	1
Record, CO	1
Heering, P	1
Westhoff, A	1
Bach, D	1
Sprenger, KB	1
Passlick, J	1
Helmchen, U	1
Grabensee, B	1
Williams, ME	1
Epstein, FH	1
Radó, J	1
Berg, KJ	1
Førre, O	1
Bjerkhoel, F	1
Amundsen, E	1
Djøseland, O	1
Rugstad, HE	1
Westre, B	1
Usberti, M	1
Pecoraro, C	1
Federico, S	1
Guida, B	1
Romano, A	1
Grumetto, L	1
Carbonaro, L	1
Bernardi, M	1
Santini, C	1
Trevisani, F	1
Baraldini, M	1
Ligabue, A	1
Gasbarrini, G	1
Statius van Eps, LW	1
Tareeva, IE	1
Kutyrina, IM	1
Nishikawa, T	1
Dohi, S	1
Sugino, N	1
Pupita, F	1
Campolucci, G	1
Pulido, M	1
Belogi, M	1
Rotatori, P	1
Ansuini, R	1
Frausini, G	1
Barone, A	1
Gaggi, S	1
Kawabe, K	1
Sokabe, H	1
Godard, C	2
Mégevand, A	1
de Sousa, RC	1
Muller, AF	2
Brackett, NC	2
Koppel, M	1
Randall, RE	1
Nixon, WP	1
Markov, KhM	2
Gerasimova, EN	1
Pal, S	1
Zamyslova, KN	1
Nekrasova, AA	1
Pal, SP	1
Raeva, IP	1
Ryzhikov, VA	1
Speranskiĭ, MD	1
Gross, F	1
Kokot, F	1
Kuska, J	1
Czekala, Z	1
Kiecoń, I	1
Fleischer, N	1
Brown, H	1
Graham, DY	1
Deleña, S	1
Tanaka, T	1
Kobayashi, H	1
Honda, H	1
Fukuda, T	1
Miyama, S	1
Sims, EA	1
Desmit, EM	1
Cost, WS	1
Brown, JJ	2
Fraser, R	2
Lever, AF	2
Robertson, JI	2
Condorelli, M	1
Peschle, C	1
Tallarida, G	1
Rengo, F	1
Critelli, G	1
Santucci, A	1
Kaplan, NM	2
Arant, BS	1
Young, RB	1
Still, WJ	1
Veyrat, R	1
Grandchamp, A	1
Scholer, D	1
Fukuchi, S	1
Boyd, GW	1
Peart, WS	1
Bayard, F	1
Cooke, CR	1
Beitins, IZ	1
Migeon, CJ	1
White, MG	1
Baer, L	2
Buhler, FR	2
Sealey, JE	1
Vaughan, ED	2
Stein, JH	1
Ferris, TF	1
Ramanathan, K	1
Gantt, C	1
Grossman, A	1
Modlinger, RS	1
Nicolis, GL	1
Gabrilove, JL	1
Cousins, MJ	1
Mazze, RI	1
Berman, LB	1
Vertes, V	1
Distler, A	1
Nakada, T	1
Momose, G	1
Yoshida, T	1
Tateno, Y	1
Shigematsu, H	1
Birkhäuser, M	1
Loirat, C	1
Vallotton, MB	1
Brod, J	1
Vick, H	1
Potter, WZ	1
Trygstad, CW	1
Helmer, OM	1
Nance, WE	1
Judson, WE	1
Mantero, F	1
Armanini, D	1
Urbani, S	1
Nielsen, I	1
Jacobsen, JG	1
Olesen, KH	1
Baranowska, B	1
Jones, J	1
Klahr, S	1
Slatopolsky, E	1
Kissane, JM	1
Nakagawa, S	1
Yamada, T	1
Kitaoka, T	1
Koshikawa, S	1
Mills, IH	1
Shapiro, AP	1
Read, VH	1
McCaa, CS	1
Bower, JD	1
McCaa, RE	1
Dustan, HP	1
Tarazi, RC	1
Bravo, EL	1
Dart, RA	1
Takeda, R	1
Morimoto, S	1
Kuroda, M	1
Murakami, M	1
Orlowski, Z	1
Cannon, PJ	1
Leeming, JM	1
Sommers, SC	1
Winters, RW	1
Kono, T	1
Friedberg, CK	1
Yoshida, H	1
Mizukoshi, H	1
Araki, Y	1
Aitchison, J	1
Ferriss, JB	1
Kay, AW	1
Neville, AM	1
Symington, T	1
Espiner, EA	2
Christlieb, AR	2
Amsterdam, EA	2
Jagger, PI	2
Dobrzinsky, SJ	2
Lauler, DP	2
Hickler, RB	2
Salvadori, B	1
Horrobin, DF	1
Kondo, T	1
Radice, C	1
D'Amico, E	1
Torti, G	1
Kucharska, K	1
Göhring, HJ	1
Wilbrandt, R	1
Fritz, KW	1
Sandstead, HH	1
Michelakis, AM	1
Temple, TE	1
Garella, S	1
Chazan, JA	1
Cohen, JJ	1
Krück, F	1
Gall, G	1
Vaitukaitis, J	1
Haddow, JE	1
Klein, R	1
Linshaw, MA	1
Gruskin, AB	1
Matsuda, T	1
Stefan, H	1
Helge, H	1
Merker, HJ	1
Bachmann, D	1
Campanacci, L	1
Romagnoli, GF	1
Borsatti, A	1
Mendola, R	1
Huber, W	1
Bertaglia, G	1
Riz, G	1
Gambari, PF	1
Schönbeck, M	1
Endres, P	1
Baumann, K	1
Gysling, E	1
Hills, AG	1
Vagnucci, AH	1